Trademark Registration for Pharmaceutical Companies in India (2026)
Classes for Pharma Businesses
| Product/Business | Class |
|---|---|
| Prescription drugs, OTC medicines | Class 5 |
| APIs (Active Pharmaceutical Ingredients) | Class 5 |
| Ayurvedic / homeopathic medicines | Class 5 |
| Health supplements, vitamins | Class 5 |
| Medical devices, diagnostic kits | Class 10 |
| Pharmaceutical research services | Class 42 |
| Hospital / clinic services | Class 44 |
| Pharmaceutical retail pharmacy | Class 35 |
DCGI Approval vs Trademark: Two Different Things
Hyderabad & Haridwar Pharma Clusters: Why Filing Early Matters
- Many generic drug names differ only in spelling or pronunciation — small differences matter
- A drug brand name registered by a competitor in your target segment forces expensive rebranding
- File as early as possible — even before product launch or DCGI approval submission
Drug Brand Name Strategy
- Company brand (corporate identity): Filed in Class 5 + Class 35 (pharmacy retail) + Class 42 (pharma R&D services)
- Individual drug brand names: Each formulation brand filed separately in Class 5
- International protection: For export markets, file via Madrid Protocol designating target countries
- DCGI name screening: Before investing in drug brand development, check both DCGI's list of rejected names AND IP India's Class 5 search
Frequently Asked Questions
Which class for pharmaceutical products?
Class 5 — pharmaceuticals, medicinal preparations, APIs, veterinary preparations, health supplements, and sanitary preparations.
Does DCGI approval protect my drug brand name?
No — DCGI approval authorises your product for market. Trademark registration gives you exclusive rights to the brand name. Both are needed.
Can a generic pharma company trademark its drug brand names?
Yes — generic drug manufacturers who sell under their own brand names (not just under generic INN names) need trademark registration in Class 5 for each brand name.
How do I choose a drug brand name that will be approved by both DCGI and IP India?
Avoid names that: (1) phonetically resemble existing registered drug brands (IP India search), (2) appear on DCGI's list of rejected drug names, (3) are purely descriptive of the drug's pharmacological action. Work with both a trademark attorney and a regulatory consultant simultaneously.
Expert Trademark Help
End-to-end trademark services — search, filing, objection replies, certificate follow-up. All business types, transparent fees.